Vaccine Immune Efficacy against Porcine Epidemic Diarrhea Virus (PEDV)

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Innate and Adaptive Immunity in Vaccination".

Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1861

Special Issue Editor


E-Mail Website
Guest Editor
College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea
Interests: coronavirus; virus-like particle vaccine; adjuvant; mucosal vaccine

Special Issue Information

Dear Colleagues,

PEDV is a swine, diarrhea-causing coronavirus that was first reported in 1987. Despite the use of vaccines, PEDV and PEDV variants are prevalent worldwide, causing serious economic losses to swine industries. The vaccines for PEDV are mainly attenuated and inactivated vaccines. Various studies will need to be conducted to re-evaluate the effectiveness of existing vaccines and to establish vaccines for new platforms. 

Therefore, we invite you to submit a research article or a review article discussing the different PEDV vaccines and adjuvants, as well as the novel development and investigation of its mechanisms of action, advanced manufacturing, characterization methods and preclinical investigations.

Prof. Dr. Jung-Eun Park
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • porcine epidemic diarrhea virus
  • vaccines
  • protection
  • immune response

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 305 KiB  
Review
Porcine Epidemic Diarrhea: Insights and Progress on Vaccines
by Jung-Eun Park
Vaccines 2024, 12(2), 212; https://doi.org/10.3390/vaccines12020212 - 18 Feb 2024
Viewed by 1450
Abstract
Porcine epidemic diarrhea (PED) is a swine-wasting disease caused by coronavirus infection. It causes great economic damage to the swine industry worldwide. Despite the continued use of vaccines, PED outbreaks continue, highlighting the need to review the effectiveness of current vaccines and develop [...] Read more.
Porcine epidemic diarrhea (PED) is a swine-wasting disease caused by coronavirus infection. It causes great economic damage to the swine industry worldwide. Despite the continued use of vaccines, PED outbreaks continue, highlighting the need to review the effectiveness of current vaccines and develop additional vaccines based on new platforms. Here, we review existing vaccine technologies for preventing PED and highlight promising technologies that may help control PED virus in the future. Full article
Back to TopTop